EUVIMEDEUVIMED entdecken
Crossref

Clinical Features of Hidradenitis Suppurativa in Down Syndrome Patients: A Multicenter Spanish Study

Maria Sin-Soler iD, Patricia Garbayo-Salmons iD, María Olivares-Guerrero, Yolanda Delgado-Jiménez, Verónica Mora-Fernández iD, José Carlos Pascual, Alberto Soto-Moreno, Alejandro Molina-Leyva, Inés Gracia-Darder, Rafael S Aguayo-Ortiz, Gemma Martin-Ezquerra, Mar Luque-Luna und 8 weitere

Journal of Cutaneous Medicine and Surgery · 03.06.2026

DOI: 10.1177/12034754261453366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Medicine and Surgery, online erschienen am 03.06.2026. Verfasst von Maria Sin-Soler und 19 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Parc Taulí Hospital Universitari, Institut d'Investigacio i Innovacio Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcel…. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Academia Española de Dermatología y Venereología (AEDV)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current evidence indicates a significant association between hidradenitis suppurativa (HS) and Down syndrome (DS), though the underlying mechanisms remain unclear.

Objective

To describe the demographic profile and clinical manifestations of HS in patients with DS, including phenotype, disease severity, comorbidities, and therapeutic approaches.

Methods

This was an observational, cross-sectional, retrospective, multicenter study including consecutive patients with both DS and HS across 15 Spanish hospitals. Primary endpoints were HS clinical phenotype and severity; secondary endpoints included comorbidities and therapeutic burden.

Results

Sixty-nine patients with DS and HS were included. Phenotypic data were available for 68 patients (98.6%), with 38.2% classified as inflammatory, 30.9% as follicular, and 30.9% as mixed phenotype. The median (interquartile range) age at disease onset was 15.0 years (13.0-18.3), and the age at diagnosis was 20.0 years (16.0-30.0). Most patients (50.7%) had Hurley stage I disease. The most affected sites were the groin (69.6%) and axilla (63.8%). The inflammatory phenotype group showed a significantly higher prevalence of systemic hypertension, dyslipidemia, endocrinological disorders (particularly hypothyroidism), and cardiovascular disease compared to the other phenotypes ( P = .0475, .0493, and .0042, respectively). Treatment strategies did not differ significantly across phenotypes.

Conclusions

Patients with both DS and HS had an earlier disease onset than the general HS population. Most patients were stage I, with axillae and groin affected. The inflammatory phenotype was associated with an increased prevalence of systemic hypertension, dyslipidemia, endocrine comorbidities (especially hypothyroidism), and cardiovascular disease. Finally, this study suggested that DS did not contraindicate or restrict the use of HS treatments.

Schlagwörter

Stichwörter der Autor:innen

Down syndromecomorbiditieshidradenitis suppurativaphenotypestreatments

Autor:innen und Institutionen

  • Dermatology Department, Parc Taulí Hospital Universitari, Institut d'Investigacio i Innovacio Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Dermatology Department, Hospital Universitario de La Princesa, Madrid, Spain.
  • Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Dermatology Department, Dr Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Spain.
  • Dermatology Department, Hospital Universitario Virgen de las Nieves-Ibs, Granada, Spain.
  • Dermatology Department, University of Granada, Spain.

ORCID-Profile: Maria Sin-Soler, Patricia Garbayo-Salmons, Verónica Mora-Fernández, Miguel Mansilla-Polo

Förderung

  • Academia Española de Dermatología y Venereología (AEDV).

Zitieren

APA

Sin-Soler, M., Garbayo-Salmons, P., Olivares-Guerrero, M., Delgado-Jiménez, Y., Mora-Fernández, V., Pascual, J. C., Soto-Moreno, A., Molina-Leyva, A., Gracia-Darder, I., Aguayo-Ortiz, R. S., Martin-Ezquerra, G., Luque-Luna, M., Fuertes, I., Vilarrasa, E., Romaní, J., Vidal Sarró, D., Mansilla-Polo, M., Matas-Nadal, C., Fornons-Servent, R., & Martorell, A. (2026). Clinical Features of Hidradenitis Suppurativa in Down Syndrome Patients: A Multicenter Spanish Study. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754261453366

Vancouver

Sin-Soler M, Garbayo-Salmons P, Olivares-Guerrero M, Delgado-Jiménez Y, Mora-Fernández V, Pascual JC, et al. Clinical Features of Hidradenitis Suppurativa in Down Syndrome Patients: A Multicenter Spanish Study. Journal of Cutaneous Medicine and Surgery. 2026. doi:10.1177/12034754261453366

BibTeX
@article{SinSoler2026,
  author = {Sin-Soler, Maria and Garbayo-Salmons, Patricia and Olivares-Guerrero, María and Delgado-Jiménez, Yolanda and Mora-Fernández, Verónica and Pascual, José Carlos and Soto-Moreno, Alberto and Molina-Leyva, Alejandro and Gracia-Darder, Inés and Aguayo-Ortiz, Rafael S and Martin-Ezquerra, Gemma and Luque-Luna, Mar and Fuertes, Irene and Vilarrasa, Eva and Romaní, Jorge and Vidal Sarró, David and Mansilla-Polo, Miguel and Matas-Nadal, Clara and Fornons-Servent, Rosa and Martorell, Antonio},
  title = {Clinical Features of Hidradenitis Suppurativa in Down Syndrome Patients: A Multicenter Spanish Study},
  journal = {Journal of Cutaneous Medicine and Surgery},
  year = {2026},
  doi = {10.1177/12034754261453366}
}
Kostenlos starten →